AN2 Therapeutics, Inc. (ANTX) vs Satellos Bioscience Inc. (MSLE)
AN2 Therapeutics, Inc. and Satellos Bioscience Inc. are both Biotechnology companies. AN2 Therapeutics, Inc. and Satellos Bioscience Inc. are of similar size ($184.8M and $184.5M). Across the 8 metrics below, AN2 Therapeutics, Inc. leads on 7 and Satellos Bioscience Inc. on 1.
Valuation
Profitability
| Metric | ANTX | MSLE | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (50.12%) | (70.45%) | (57.72%) |
| Return on assets | (46.06%) | (64.76%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack